发布于 · 2024年8月1日 · 语音AI · 认知退化 · Alzheimer's · 数字生物标志物
远端数字语音声学评估于认知正常成人之可行性、可靠性与淀粉样蛋白病理之关联
多日远端语音评估具高可行性与可靠性，且对淀粉样蛋白相关变化具潜在敏感性，支持其作为早期 Alzheimer's 病数字生物标志物的开发。
Remote multi-day speech assessment is feasible, reliable, and potentially sensitive to amyloid-beta-related changes in cognitively unimpaired older adults, supporting its development as a digital biomarker for early Alzheimer’s disease.